CR10420A - Derivados biciclicos como inhibibidores de cetp - Google Patents
Derivados biciclicos como inhibibidores de cetpInfo
- Publication number
- CR10420A CR10420A CR10420A CR10420A CR10420A CR 10420 A CR10420 A CR 10420A CR 10420 A CR10420 A CR 10420A CR 10420 A CR10420 A CR 10420A CR 10420 A CR10420 A CR 10420A
- Authority
- CR
- Costa Rica
- Prior art keywords
- inhibibers
- cetp
- present
- bicycle derivatives
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
La presente invencion se refiere a novedosos compuestos de la Formula (I): o una composicion farmaceutica de los mismos, estando todas las variables definidas en el texto. La presente invencion se refiere ademas la uso de los compuestos de la presente para el tratamiento de, o demora de progreso para superar, las enfermedades en donde este involucrada la proteina de transferencia de colesteril-ester.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0609268.8A GB0609268D0 (en) | 2006-05-10 | 2006-05-10 | Organic compounds |
US86648006P | 2006-11-20 | 2006-11-20 | |
US89614207P | 2007-03-21 | 2007-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10420A true CR10420A (es) | 2009-02-02 |
Family
ID=38445602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10420A CR10420A (es) | 2006-05-10 | 2008-10-30 | Derivados biciclicos como inhibibidores de cetp |
Country Status (17)
Country | Link |
---|---|
US (2) | US8232403B2 (es) |
EP (1) | EP2024356A1 (es) |
KR (1) | KR101172120B1 (es) |
AR (1) | AR060873A1 (es) |
AU (1) | AU2007247385B2 (es) |
CA (1) | CA2650954C (es) |
CL (1) | CL2007001325A1 (es) |
CR (1) | CR10420A (es) |
EC (1) | ECSP088891A (es) |
GT (1) | GT200800242A (es) |
IL (1) | IL195010A0 (es) |
MA (1) | MA30427B1 (es) |
MX (1) | MX2008014284A (es) |
NO (1) | NO20084912L (es) |
TN (1) | TNSN08444A1 (es) |
TW (1) | TW200813009A (es) |
WO (1) | WO2007128568A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
EP1848430B1 (en) | 2004-12-31 | 2017-08-02 | Dr. Reddy's Laboratories Ltd. | Novel benzylamine derivatives as cetp inhibitors |
BRPI0620754A2 (pt) * | 2005-12-29 | 2011-11-22 | Novartis Ag | derivados de amina de piridinila como inibidores de proteìna de transferência de éster de colesterila (cetp) |
MX2008014284A (es) * | 2006-05-10 | 2008-11-18 | Novartis Ag | Derivados biciclicos como inhibidores de cetp. |
WO2007132906A1 (en) * | 2006-05-11 | 2007-11-22 | Novartis Ag | Benzylamine derivatives as cetp inhibitors |
US7750019B2 (en) | 2006-08-11 | 2010-07-06 | Kowa Company, Ltd. | Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same |
US7790737B2 (en) | 2007-03-13 | 2010-09-07 | Kowa Company, Ltd. | Substituted pyrimidine compounds and their utility as CETP inhibitors |
MX2009010962A (es) | 2007-04-13 | 2009-12-16 | Kowa Co | Compuesto pirimidina novedoso que tiene estructura de dibencilamina y medicamento que comprende el mismo. |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US8841478B2 (en) | 2008-11-28 | 2014-09-23 | Kowa Company, Ltd. | Method for preparing trans-{4-[(alkylamino) methyl]- cyclohexyl}acetic acid ester |
CA2772714C (en) | 2009-09-03 | 2017-09-26 | Bioenergenix | Heterocyclic compounds for the inhibition of pask |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
CA2841117A1 (en) | 2011-07-08 | 2013-01-17 | Novartis Ag | 1,2-disubstituted-4-benzylamino-piperidinyl derivatives as cetp inhibitors useful for the treatment of atherosclerosis in high triglyceride subjects |
WO2013024358A2 (en) | 2011-08-18 | 2013-02-21 | Dr. Reddy's Laboratories Ltd. | Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (cetp) inhibitors |
WO2013046045A1 (en) | 2011-09-27 | 2013-04-04 | Dr. Reddy's Laboratories, Ltd. | 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester -transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis |
US20170071930A1 (en) * | 2012-11-19 | 2017-03-16 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions of cetp inhibitors |
UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
US20160000799A1 (en) * | 2013-02-21 | 2016-01-07 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical compositions of cetp inhibitors |
UY35671A (es) | 2013-07-25 | 2015-02-27 | Novartis Ag | Bioconjugados de polipéptidos de apelina sintética |
SG11201600211XA (en) | 2013-07-25 | 2016-02-26 | Novartis Ag | Cyclic polypeptides for the treatment of heart failure |
MA41580A (fr) | 2015-01-23 | 2017-11-29 | Novartis Ag | Conjugués d'acides gras de l'apeline synthétique présentant une demi-vie améliorée |
AU2020400010B2 (en) * | 2019-12-11 | 2024-01-25 | Ryvu Therapeutics S.A. | Heterocyclic compounds as modulators of Stimulator of Interferon Genes (STING) |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6583183B2 (en) * | 1999-09-23 | 2003-06-24 | Pharmacia Corporation | Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
CA2420967A1 (en) * | 2000-08-07 | 2002-02-14 | Neurogen Corporation | Heterocyclic compounds as ligands of the gabaa receptor |
DE60311821T2 (de) | 2002-08-30 | 2007-10-31 | Japan Tobacco Inc. | Dibenzylaminverbindung und deren medizinische verwendung |
WO2004043925A2 (en) | 2002-11-08 | 2004-05-27 | Neurogen Corporation | 3-substituted-6-aryl pyridined as ligands of c5a receptors |
AU2004224082A1 (en) | 2003-03-28 | 2004-10-07 | Pfizer Products Inc. | 1,2,4-substitute 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as CETP inhibitors for the treatment of atherosclerosis and obesity |
US7371759B2 (en) * | 2003-09-25 | 2008-05-13 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
CN1942428A (zh) | 2004-04-13 | 2007-04-04 | 默克公司 | Cetp抑制剂 |
WO2006056854A1 (en) | 2004-11-23 | 2006-06-01 | Pfizer Products Inc. | Dibenzyl amine compounds and derivatives |
US7668830B2 (en) | 2004-11-29 | 2010-02-23 | Nokia Corporation | Access rights |
EP1848430B1 (en) * | 2004-12-31 | 2017-08-02 | Dr. Reddy's Laboratories Ltd. | Novel benzylamine derivatives as cetp inhibitors |
CN101099395B (zh) | 2005-01-06 | 2012-04-04 | 汤姆森特许公司 | 减少数字光投影系统中的彩虹假像 |
CN101218497B (zh) | 2005-07-07 | 2012-04-25 | 索尼株式会社 | 利用瞬逝光的物质信息获取方法和物质信息测量装置、以及碱基序列确定方法和装置 |
US7573978B2 (en) | 2005-07-11 | 2009-08-11 | University Of Florida Research Foundation, Inc. | Variable feathering field splitting for intensity modulated fields of large size |
EP1981342B1 (en) | 2005-12-28 | 2016-11-30 | Dr. Reddy's Laboratories Ltd. | Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
BRPI0620754A2 (pt) * | 2005-12-29 | 2011-11-22 | Novartis Ag | derivados de amina de piridinila como inibidores de proteìna de transferência de éster de colesterila (cetp) |
PE20071025A1 (es) * | 2006-01-31 | 2007-10-17 | Mitsubishi Tanabe Pharma Corp | Compuesto amina trisustituido |
MX2008014284A (es) * | 2006-05-10 | 2008-11-18 | Novartis Ag | Derivados biciclicos como inhibidores de cetp. |
WO2007132906A1 (en) * | 2006-05-11 | 2007-11-22 | Novartis Ag | Benzylamine derivatives as cetp inhibitors |
KR20090078352A (ko) * | 2006-11-15 | 2009-07-17 | 노파르티스 아게 | 유기 화합물 |
CN101535293A (zh) * | 2006-11-15 | 2009-09-16 | 诺瓦提斯公司 | 作为cetp抑制剂的杂环衍生物 |
-
2007
- 2007-05-08 MX MX2008014284A patent/MX2008014284A/es active IP Right Grant
- 2007-05-08 EP EP07724982A patent/EP2024356A1/en not_active Withdrawn
- 2007-05-08 AU AU2007247385A patent/AU2007247385B2/en not_active Ceased
- 2007-05-08 AR ARP070101992A patent/AR060873A1/es unknown
- 2007-05-08 KR KR1020087030049A patent/KR101172120B1/ko not_active IP Right Cessation
- 2007-05-08 WO PCT/EP2007/004058 patent/WO2007128568A1/en active Application Filing
- 2007-05-08 US US12/300,208 patent/US8232403B2/en not_active Expired - Fee Related
- 2007-05-08 CA CA2650954A patent/CA2650954C/en not_active Expired - Fee Related
- 2007-05-09 CL CL200701325A patent/CL2007001325A1/es unknown
- 2007-05-09 TW TW096116482A patent/TW200813009A/zh unknown
-
2008
- 2008-10-30 CR CR10420A patent/CR10420A/es not_active Application Discontinuation
- 2008-10-30 IL IL195010A patent/IL195010A0/en unknown
- 2008-11-06 TN TNP2008000444A patent/TNSN08444A1/en unknown
- 2008-11-07 GT GT200800242A patent/GT200800242A/es unknown
- 2008-11-10 EC EC2008008891A patent/ECSP088891A/es unknown
- 2008-11-21 NO NO20084912A patent/NO20084912L/no not_active Application Discontinuation
- 2008-11-24 MA MA31408A patent/MA30427B1/fr unknown
-
2012
- 2012-05-17 US US13/473,649 patent/US8410275B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL195010A0 (en) | 2009-08-03 |
CA2650954A1 (en) | 2007-11-15 |
KR101172120B1 (ko) | 2012-08-10 |
US20090227580A1 (en) | 2009-09-10 |
MX2008014284A (es) | 2008-11-18 |
US8232403B2 (en) | 2012-07-31 |
CA2650954C (en) | 2014-02-11 |
KR20090017580A (ko) | 2009-02-18 |
GT200800242A (es) | 2009-04-29 |
TW200813009A (en) | 2008-03-16 |
WO2007128568A1 (en) | 2007-11-15 |
US8410275B2 (en) | 2013-04-02 |
AU2007247385B2 (en) | 2011-07-14 |
TNSN08444A1 (en) | 2010-04-14 |
CL2007001325A1 (es) | 2008-07-18 |
AU2007247385A1 (en) | 2007-11-15 |
EP2024356A1 (en) | 2009-02-18 |
US20120225874A1 (en) | 2012-09-06 |
ECSP088891A (es) | 2008-12-30 |
MA30427B1 (fr) | 2009-05-04 |
NO20084912L (no) | 2009-02-03 |
AR060873A1 (es) | 2008-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR10420A (es) | Derivados biciclicos como inhibibidores de cetp | |
CY1118061T1 (el) | Δικυκλικα παραγωγα heterocyclyl σαν καταστολεις κινασης (kinase) fgfr για θεραπευτικη χρηση | |
EA201100969A1 (ru) | Солевые формы органического соединения | |
CR10614A (es) | Derivados heterociclicos fusionados y metodos de uso | |
ECSP088414A (es) | Derivados de ácido bifeniloxiacético para el tratamiento de una enfermedad respiratoria | |
CR10875A (es) | Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides | |
ECSP10010582A (es) | Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer | |
EA201001555A1 (ru) | Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17 | |
GT201000023A (es) | Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met. | |
BRPI0721905B8 (pt) | composto inibidor de proteassoma, sua composição farmacêutica e seu uso | |
ECSP10010433A (es) | Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas | |
EA201170772A1 (ru) | Органические соединения | |
ECSP109903A (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
UY30578A1 (es) | Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones | |
PA8842101A1 (es) | Heteroarilos sustituidos | |
SV2011003903A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa iv para el tratamiento o prevencion de diabetes | |
UY30481A1 (es) | Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos. | |
EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
UY29414A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
CR10356A (es) | Derivados de 4-benzilphthalazinona 2-sustituidos como antagonistas de histamina h1 y h3 | |
ECSP10010599A (es) | Derivados de tienopiridonas como activadores de proteina quinasa activados por amp (ampk) | |
UY29223A1 (es) | Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación | |
CR10948A (es) | Compuestos triciclicos, composiciones y procedimientos | |
BRPI0911035B8 (pt) | ativadores de pirrolidinona glicoquinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |